Adverse events110

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

1 to 20 of 110

Type	Event	Organ system	Group	Affected	At risk	Events
other	Anemia	Blood and lymphatic system disorders	Regorafenib + Oxaliplatin/Folinic Acid/5-FU (mFOLFOX6)	12	53	25
other	Conduction disorder	Cardiac disorders	Regorafenib + Oxaliplatin/Folinic Acid/5-FU (mFOLFOX6)	4	53	8
other	Sinus bradycardia	Cardiac disorders	Regorafenib + Oxaliplatin/Folinic Acid/5-FU (mFOLFOX6)	3	53	3
other	Hypothyroidism	Endocrine disorders	Regorafenib + Oxaliplatin/Folinic Acid/5-FU (mFOLFOX6)	6	53	8
other	Abdominal pain	Gastrointestinal disorders	Regorafenib + Oxaliplatin/Folinic Acid/5-FU (mFOLFOX6)	28	53	47
other	Constipation	Gastrointestinal disorders	Regorafenib + Oxaliplatin/Folinic Acid/5-FU (mFOLFOX6)	17	53	26
other	Diarrhea	Gastrointestinal disorders	Regorafenib + Oxaliplatin/Folinic Acid/5-FU (mFOLFOX6)	37	53	124
other	Dyspepsia	Gastrointestinal disorders	Regorafenib + Oxaliplatin/Folinic Acid/5-FU (mFOLFOX6)	6	53	7
other	Mucositis oral	Gastrointestinal disorders	Regorafenib + Oxaliplatin/Folinic Acid/5-FU (mFOLFOX6)	24	53	65
other	Nausea	Gastrointestinal disorders	Regorafenib + Oxaliplatin/Folinic Acid/5-FU (mFOLFOX6)	28	53	70
other	Gastrointestinal disorders - Other, specify	Gastrointestinal disorders	Regorafenib + Oxaliplatin/Folinic Acid/5-FU (mFOLFOX6)	4	53	4
other	Rectal pain	Gastrointestinal disorders	Regorafenib + Oxaliplatin/Folinic Acid/5-FU (mFOLFOX6)	4	53	4
other	Vomiting	Gastrointestinal disorders	Regorafenib + Oxaliplatin/Folinic Acid/5-FU (mFOLFOX6)	16	53	29
other	Fatigue	General disorders	Regorafenib + Oxaliplatin/Folinic Acid/5-FU (mFOLFOX6)	34	53	92
other	Fever	General disorders	Regorafenib + Oxaliplatin/Folinic Acid/5-FU (mFOLFOX6)	10	53	18
other	Infusion related reaction	General disorders	Regorafenib + Oxaliplatin/Folinic Acid/5-FU (mFOLFOX6)	3	53	7
other	Injection site reaction	General disorders	Regorafenib + Oxaliplatin/Folinic Acid/5-FU (mFOLFOX6)	4	53	4
other	General disorders and administration site conditions - Other, specify	General disorders	Regorafenib + Oxaliplatin/Folinic Acid/5-FU (mFOLFOX6)	3	53	4
other	Pain	General disorders	Regorafenib + Oxaliplatin/Folinic Acid/5-FU (mFOLFOX6)	13	53	15
other	Alanine aminotransferase increased	Investigations	Regorafenib + Oxaliplatin/Folinic Acid/5-FU (mFOLFOX6)	10	53	27

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT01289821/events

API reference For AI assistants

Adverse events110

Sources 3

Read this list from software.